United Kingdom Life Science Trend Analysis 2021

2020 was a great year for the British biotech industry. The total value of private equity investments was twice as high compared to 2019 and exceeded the 2018 level that had been the highest since we begun tracking data. The UK remains the largest life science market in Europe when it comes to the number … Continue reading United Kingdom Life Science Trend Analysis 2021

Read more

UK Life Science Market Trend Analysis 2020

The number of financing rounds scored by UK private biotech companies in 2019 was the lowest since 2016. However, it still stays at a decent level and there is no sign of the British life science industry losing its position as the largest in Europe. Biotechgate lists more than 4,000 British companies that altogether have … Continue reading UK Life Science Market Trend Analysis 2020

Read more

UK Life Sciences Trend Analysis 2019

The United Kingdom is the largest European market when it comes to the number of life science companies. There are over 1,200 biotech companies based there with the total number of about 900 biopharmaceutical products being currently developed. 2018 was the record year in terms of the level of financing – 1,777 million USD was … Continue reading UK Life Sciences Trend Analysis 2019

Read more

UK Life Sciences Trend Analysis 2018

The UK market remains one of the strongest in Europe. The total value of venture investments in biotech and other life science companies was lower in 2017 than in two previous years, but the number of financing rounds was impressive.

Read more

UK Life Sciences Trend Analysis 2017

2016 was a quiet year for the UK Life Science Industry. After the relatively good first half of the year when more than twenty financing rounds were noted with over USD 500m invested, the second half saw a significant drop in financing activities. UK Life Science Trend Analysis 2017   Looking for your next Biotech … Continue reading UK Life Sciences Trend Analysis 2017

Read more

UK Life Sciences Trend Analysis 2014

2013 closed with the total venture financing value raised by Biotech companies in the U.K. being decreased by 47% compared to its 2012 level (USD 283m in 2013 compared to USD 530m in 2012). The number of U.K. biotech products (therapeutics and diagnostics) in the first stage of the clinical pipeline (Phase I) was increased … Continue reading UK Life Sciences Trend Analysis 2014

Read more